Skip to content

Study · Randomized controlled trial · 1995

1 result

Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate.

Sungurtekin U, Jansen RP

Fertility and sterility1 Mar 1995Cited by 20 (Europe PMC)

PMID7851604 (opens in a new tab)DOI10.1016/s0015-0282(16)57443-3 (opens in a new tab)PepBankPUB-07851604
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In women undergoing ovarian stimulation, LH fell profoundly after stopping leuprolide after 5 days compared with continued leuprolide.

    In plain wordsLH fell after stopping leuprolide after 5 days compared with continued treatment.

    Peptide
    Leuprolide
    Outcome
    DecreaseLH after leuprolide discontinuation
    Study

    n: not reported in source

    Comparator
    Continued leuprolide
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · 5 days before discontinuationAs given in this study (human).

    Source sentences

    Summary
    When LA was stopped after 5 days of administration, LH levels fell profoundly when compared with levels when LA was continued.
    3 context sentences
    Summary · context
    Women undergoing controlled ovarian stimulation for assisted conception were randomized to receive LA according to "short" or "ultrashort" protocols.
    Summary · context
    The alternative protocol was used then in a second cycle.
    Summary · context
    Each patient was thus her own control.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.